Monday, June 13th, 2016 - WiseGuyReports

The Global Nuclear Medicine Market accounted for $8.8 billion in 2014 and is expected to grow at a CAGR of 9.6% to reach $20.4 billion by 2022. Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person's specific organs, or to treat them. According to World nuclear association, Over 10,000 hospitals across the world use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most commonly used radioisotope in diagnosis is technetium-99, accounting for more than 80% of all nuclear medicine procedures worldwide. Computed X-ray tomography (CT) scans and nuclear medicine contribute 36% of the total radiation exposure and 75% of the medical exposure to the U.S. population, according to a US National Council on Radiation Protection & Measurements report.

Complete report details @ https://www.wiseguyreports.com/reports/nuclear-medicine-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022     

 

Factors driving the nuclear medicine market include advancements in radiotracers, increasing number of patients with cancer and cardiovascular ailment, increasing use of SPECT and PET scan results and alpha radio immunotherapy-based targeted cancer treatment. However, factors such as stringent regulatory guidelines, high capital investment, shorter half-life of radiopharmaceuticals and competition from conventional diagnostic procedures are inhibiting the growth of nuclear medicine market. Technological advancements in neurological applications and increasing demand from emerging countries are likely to create huge opportunities for the market growth.

Request a sample report @ https://www.wiseguyreports.com/sample-request/nuclear-medicine-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022    

 

The Global nuclear medicine market is segmented on the basis of type, application and geography. By type, the market is classified into nuclear medicine diagnostic market and nuclear medicine therapeutic isotopes market. Based on the application, the nuclear medicine market is categorized into diagnostics and therapeutics applications. The diagnostic application is further segmented into SPECT and PET market, where SPECT market comprises cardiology, neurology, thyroid and other diagnostic applications. The PET market comprises oncology and other PET applications. The therapeutics application is further segmented into thyroid, bone metastasis, endocrine tumors and other therapeutic applications. By geography, it is segmented into North America, Europe, Asia Pacific and Rest of the World. North America followed by the Europe dominates the global nuclear medicine market.

Some of the key players in nuclear medicine market include GE Healthcare (U.K.), Nordion, Inc. (Canada), Bayer Healthcare (Germany), Cardinal Health, Inc. (U.S.), Siemens Healthcare (PETNET) (Germany)., IBA Group (Belgium), Lantheus Medical Imaging, Inc. (U.S.), Eczacibasi-Monrol Nuclear Products (Turkey), Ashby Gorman Baker Ltd, and Mediso Ltd.

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/nuclear-medicine-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022   

 

What our report offers: 
- Market share assessments for the regional and country level segments 
- Market share analysis of the top industry players 
- Strategic recommendations for the new entrants 
- Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets 
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
- Strategic recommendations in key business segments based on the market estimations 
- Competitive landscaping mapping the key common trends 
- Company profiling with detailed strategies, financials, and recent developments 
- Supply chain trends mapping the latest technological advancements

Table of content

1 Executive Summary 

2 Preface 
2.1 Abstract 
2.2 Research Scope 
2.3 Research Methodology 
2.4 Research Sources 

3 Market Trend Analysis 
3.1 Introduction 
3.2 Drivers 
3.3 Restraints 
3.4 Opportunities 
3.5 Threats 

4 Porters Five Force Analysis 
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes 
4.4 Threat of new entrants 
4.5 Competitive rivalry 

5 Global Nuclear Medicine Market, By Type 
5.1 Introduction 
5.2 Nuclear Medicine Diagnostic Market 
5.2.1 SPECT 
5.2.1.1 Introduction 
5.2.1.2 GAllium-67 (GA-67) 
5.2.1.3 Technetium-99m (TC-99m) 
5.2.1.4 Others 
5.2.2 PET 
5.2.2.1 Introduction 
5.2.2.2 Fluorine-18 (F-18) 
5.2.2.3 Rubidium-82 (RB-82) 
5.2.2.4 Others 
5.3 Nuclear Medicine Therapeutic Isotopes Market 
5.3.1 Alpha Emitters 
5.3.1.1 Introduction 
5.3.1.2 Radium-223 (RA-223) 
5.3.2 Beta Emitters 
5.3.2.1 Introduction 
5.3.2.2 Yttrium-90 (Y-90) 
5.3.2.3 Samarium-153 (SM-153) 
5.3.2.4 Lutetium-177 (Lu-177) 
5.3.3 Brachytherapy 
5.3.3.1 Iodine-125 
5.3.3.2 Palladium-103 
5.3.3.3 Cesium-131 
5.3.3.4 Others 

6 Global Nuclear Medicine Market, By Applications 
6.1 Introduction 
6.2 Diagnostics 
6.2.1 Single proton emission tomography (SPECT) 
6.2.1.1 Cardiology 
6.2.1.2 Neurology 
6.2.1.3 Thyroid 
6.2.1.4 Other SPECT applications 
6.2.2 Positron emission tomography (PET) 
6.2.2.1 Oncology 
6.2.2.2 Other PET applications 
6.3 Therapeutics 
6.3.1 Thyroid 
6.3.2 Bone metastasis 
6.3.3 Endocrine tumors 
6.3.4 Other therapeutic applications 

7 Global Nuclear Medicine Market, By Geography 
7.1 North America 
7.1.1 US 
7.1.2 Canada 
7.2 Europe 
7.2.1 Germany 
7.2.2 France 
7.2.3 Italy 
7.2.4 UK 
7.2.5 Spain 
7.3 Asia Pacific 
7.3.1 Japan 
7.3.2 China 
7.3.3 India 
7.3.4 Australia 
7.3.5 New Zealand 
7.3.7 Rest of Asia 
7.4 Rest of the World 
7.4.1 Latin America 
7.4.2 Middle East 
7.4.3 Africa 
7.4.4 Others 

8 Key Developments 
8.1 Agreements, Partnerships, Collaborations and Joint Ventures 
8.2 Acquisitions & Mergers 
8.3 New Product Launch 
8.4 Expansions 
8.5 Other Key Strategies 

9 Company Profiling 
9.1 GE Healthcare (U.K.) 
9.2 Nordion, Inc. (Canada) 
9.3 Bayer Healthcare (Germany) 
9.4 Cardinal Health, Inc. (U.S.) 
9.5 Siemens Healthcare (PETNET) (Germany) 
9.6 IBA Group (Belgium) 
9.7 Lantheus Medical Imaging, Inc. (U.S.) 
9.8 Eczacibasi-Monrol Nuclear Products (Turkey) 
9.9 Ashby Gorman Baker Ltd 
9.10 Mediso Ltd. 

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=222088

 

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)          

 

 

 

 

File Library

Contact Profile

WiseGuyReports


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.


Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349
W: www.wiseguyreports.com/

Keywords

Nuclear Medicine market trend, Nuclear Medicine market segmentation, Nuclear Medicine market analysis, Nuclear Medicine market parameters, Nuclear Medicine industry forecast, Nuclear Medicine market size, Nuclear Medicine market share, Nuclear Medi

Categories

Newsrooms

Sharing

More Formats